Compared to a group of healthy controls, sickle cell disease patients had lower plasma zinc, increases in markers of oxidative stress, elevated VCAM-1, increased production of TNF-α and IL-1β, and decreased IFN-γ production at baseline. The gene discussed is IL1B; the disease is sickle cell disease.